PTC Therapeutics
PTCT
#2700
Rank
$6.51 B
Marketcap
$78.53
Share price
7.18%
Change (1 day)
54.43%
Change (1 year)

PTC Therapeutics (PTCT) - Total debt

Total debt on the balance sheet as of March 2026 : $0.39 Billion USD

According to PTC Therapeutics 's latest financial reports the company's total debt is $0.39 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

PTC Therapeutics - Total debt on balance sheet (from 2012 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$2.70 B9.55%
2024-12-31$2.47 B10.85%
2023-12-31$2.22 B52.52%
2022-12-31$1.46 B15.14%
2021-12-31$1.26 B201.91%
2020-12-31$0.42 B28.17%
2019-12-31$0.32 B114.38%
2018-12-31$0.15 B5.55%
2017-12-31$0.14 B47.6%
2016-12-31$98.21 M6.93%
2015-12-31$91.84 M
2014-12-31N/A-100%
2013-12-31$0.04 M-99%
2012-12-31$4.88 M-58.23%
2011-12-31$11.68 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
$46.99 B 11,795.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
$1.98 B 402.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$0.18 B-52.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.03 B 162.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
$79.24 M-79.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
$49.25 M-87.53%๐Ÿ‡บ๐Ÿ‡ธ USA